The UDOC.CN stock plunged 40.00% to C$0.09 on 10 Mar 2026 during market hours, trading just above its year low. Volume was 500 versus an average of 23,415, highlighting a liquidity squeeze. UniDoc Health Corp. (UDOC.CN) on the CNQ in Canada shows stretched fundamentals and volatile trading, factors likely driving the selloff. Investors should note the company’s negative EPS and extremely low market capitalisation as immediate red flags.
UDOC.CN stock: Market snapshot and intraday move
UniDoc Health Corp. (UDOC.CN) fell to C$0.09, down C$0.06 or 40.00% from the previous close of C$0.15. Trading was light at 500 shares versus an average daily volume of 23,415, indicating the move was concentration-driven.
Market cap is approximately C$7,771,508.00, with a 52-week range of C$0.09–C$0.38. The stock opened at C$0.09 and stayed at the day low, signalling selling pressure during market hours.
UDOC.CN stock: What likely triggered the drop
There is no recent earnings beat to support the price; the last recorded earnings announcement in the dataset is dated 2022-12-31 and EPS is -0.05. The sharp intraday fall links to thin liquidity and a low free float, not a clear operational update.
Sector signals add context: the healthcare sector is under pressure year-to-date and smaller telemedicine names face funding and adoption uncertainty. That sector backdrop can magnify down moves for microcaps like UniDoc.
UDOC.CN stock: Fundamentals and valuation snapshot
Key ratios show stress: PE -1.80, Price/Sales 11.15, PB -270.03, and EPS -0.05. Current ratio stands at 0.66, signaling short-term liquidity constraints. Meyka data lists operating cash flow per share at -0.04 and free cash flow per share at -0.04.
These metrics imply negative profitability and thin cash buffers. Market-cap to enterprise-value is consistent with net cash close to C$7.17M in enterprise terms, but working capital and payables metrics look stretched.
UDOC.CN stock: Technicals and trading signals
Short-term technicals are mixed: RSI 54.48 sits neutral, MACD near -0.01 shows little momentum, and the 50-day average is C$0.15 vs the 200-day average C$0.19. Bollinger Bands middle at C$0.14 with lower band C$0.10 suggests price is at the lower volatility band.
The low relative volume (relVolume 0.02) combined with an ADX of 33.28 indicates a strong trend on low participation. For traders this flags directional risk with shallow liquidity.
UDOC.CN stock: Meyka AI grade and forecast
Meyka AI rates UDOC.CN with a score of 67.05 out of 100 and assigns a B grade with a HOLD suggestion. This grade factors in S&P 500 and sector benchmarks, industry comparison, financial growth, key metrics, forecasts, and analyst consensus.
Meyka AI’s forecast model projects a monthly price of C$0.06 and a quarterly price of C$0.03. Compared with the current price C$0.09, the model implies a near-term downside of -33.33% to the monthly forecast and -66.67% to the quarterly forecast. Forecasts are model-based projections and not guarantees.
UDOC.CN stock: Risks, opportunities and price targets
Primary risks are low liquidity, potential dilution, negative cash flow, and reliance on telemedicine adoption. Financial metrics show negative operating margins and high payables days, increasing short-term risk.
Opportunities exist if UniDoc secures new contracts or funding. For scenario planning we set a conservative 3-month price target of C$0.10 and a 12-month recovery target of C$0.25 conditional on funding and revenue traction. These targets are illustrative, not recommendations.
Final Thoughts
UDOC.CN stock dropped 40.00% to C$0.09 on 10 Mar 2026 during market hours on thin volume, exposing liquidity risk for holders. Fundamentals show negative EPS (-0.05), PE -1.80, current ratio 0.66, and a market cap of C$7,771,508.00, all pointing to elevated short-term risk. Meyka AI’s forecast model projects a monthly price of C$0.06, implying a -33.33% downside versus today’s price. Our scenario price targets are C$0.10 at three months and C$0.25 at 12 months, contingent on new revenue or financing. Investors trading UDOC.CN stock on the CNQ in Canada should prioritise liquidity management and monitor funding updates and cash-flow improvements. Meyka AI-powered market analysis platform flags this name as a microcap with high volatility and material downside risk until operational or financing clarity emerges.
FAQs
Why did UDOC.CN stock fall 40% today?
The drop was driven by thin volume (500 shares vs 23,415 average), weak liquidity, and no recent positive earnings catalyst. Market sentiment toward small telemedicine microcaps has been negative, amplifying the move.
What are the key financial red flags for UDOC.CN stock?
Red flags include EPS -0.05, PE -1.80, current ratio 0.66, negative operating and free cash flow per share, and very low market cap, all of which increase short-term risk.
What does Meyka AI forecast for UDOC.CN stock?
Meyka AI’s forecast model projects a monthly price of C$0.06 and a quarterly price of C$0.03, implying downside of -33.33% and -66.67% respectively versus the current C$0.09. Forecasts are projections, not guarantees.
Is UDOC.CN stock a buy after the decline?
Given the microcap’s low liquidity, negative cash flow, and pending funding need, the current profile suggests caution. The Meyka grade is B (HOLD); investors should wait for clearer revenue or financing signals.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)